News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,911 Results
Type
Article (1931)
Company Profile (2)
Press Release (71978)
Section
Business (25335)
Career Advice (9)
Deals (4553)
Drug Development (8165)
FDA (1806)
Job Trends (799)
News (37027)
Policy (3567)
Tag
2027 BioCapital Standard (1)
Academia (99)
Accelerated approval (5)
ADA (2)
Allergies (25)
Alliances (8167)
ALS (21)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (127)
Approvals (1987)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (41)
Automation (2)
Bankruptcy (9)
Best Places to Work (584)
BIO (9)
Biologics (1)
Biosimilars (100)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (65)
Cancer (684)
Cardiovascular disease (26)
Career advice (9)
CAR-T (18)
CDC (2)
CDMO (9)
Celiac Disease (1)
Cell therapy (65)
Cervical cancer (5)
Clinical research (7782)
Collaboration (356)
Commercialization (3)
Compensation (28)
Complete response letters (7)
COVID-19 (203)
CRISPR (1)
C-suite (112)
Cystic fibrosis (9)
Data (913)
Depression (18)
Dermatology (13)
Diabetes (50)
Diagnostics (659)
Digital health (7)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (48)
Earnings (8268)
Events (7666)
Executive appointments (80)
FDA (2366)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (170)
Gene editing (7)
Generative AI (1)
Gene therapy (42)
GLP-1 (84)
Government (248)
Grass and pollen (1)
Guidances (40)
Healthcare (1099)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (31)
Infectious disease (231)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1641)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (6)
Layoffs (6)
Legal (955)
Licensing (14)
Liver cancer (22)
Longevity (3)
Lung cancer (130)
Lymphoma (58)
Machine learning (1)
Manufacturing (152)
Marketing (4)
MASH (19)
Medical device (1175)
Medtech (1196)
Mergers & acquisitions (3126)
Metabolic disorders (124)
mRNA (8)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (369)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (44)
Opinion (1)
Ovarian cancer (35)
Pain (22)
Pancreatic cancer (33)
Parkinson's disease (51)
Partnered (4)
Patents (79)
Patient recruitment (92)
Patient selection (4)
Peanut (2)
People (5223)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2103)
Phase 2 (3300)
Phase 3 (2938)
Pipeline (1450)
Policy (1)
Postmarket research (242)
Preclinical (713)
Press Release (2)
Prostate cancer (29)
Radiopharmaceuticals (29)
Rare diseases (95)
Real estate (606)
Regenerative medicine (1)
Regulatory (3122)
Reports (9)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (25)
Series A (36)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (19)
Women's health (8)
Date
Today (18)
Last 7 days (58)
Last 30 days (242)
Last 365 days (2838)
2026 (2140)
2025 (2685)
2024 (3252)
2023 (3814)
2022 (7005)
2021 (6372)
2020 (5874)
2019 (3869)
2018 (3012)
2017 (3559)
2016 (3174)
2015 (4029)
2014 (3020)
2013 (2600)
2012 (2776)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22389)
Australia (2500)
California (873)
Canada (501)
China (560)
Colorado (5)
Connecticut (29)
Delaware (9)
Europe (13591)
Florida (97)
Georgia (18)
Hawaii (1)
Illinois (47)
India (63)
Indiana (31)
Japan (373)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (696)
Michigan (9)
Minnesota (39)
Missouri (3)
Nebraska (3)
Nevada (13)
New Hampshire (1)
New Jersey (547)
New York (303)
North Carolina (132)
Northern California (377)
Ohio (7)
Oregon (1)
Pennsylvania (164)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (429)
Tennessee (6)
Texas (66)
United States (3363)
Utah (35)
Vermont (1)
Virginia (68)
Washington D.C. (3)
Washington State (64)
Wisconsin (8)
Wyoming (1)
73,911 Results for "kamada ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kamada Announces Planned Transition of Chief Financial Officer
August 12, 2026
·
3 min read
Press Releases
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
·
2 min read
Press Releases
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
September 3, 2026
·
11 min read
Press Releases
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada’s History; Affirms 2026 Annual Guidance
August 12, 2026
·
21 min read
Press Releases
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
September 17, 2026
·
7 min read
Press Releases
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
July 13, 2026
·
9 min read
Press Releases
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
August 5, 2026
·
2 min read
Press Releases
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
August 17, 2026
·
5 min read
Press Releases
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
June 1, 2026
·
5 min read
Press Releases
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
July 20, 2026
·
5 min read
1 of 7,392
Next
